Practical Mounjaro Advice From a Clinician-Led UK Pharmacy

What the trial evidence tells us — and what it means for you

The SURMOUNT-1 trial, involving 2,539 adults with obesity and no diabetes over 72 weeks, is the cornerstone of UK advice on Mounjaro. Participants taking 15 mg lost around 20–21% of body weight on average. Those results underpinned NICE's decision to recommend tirzepatide in December 2024, detailed in NICE technology appraisal TA1026. If you want to understand how that decision was reached and what criteria shaped it, our NICE Mounjaro guidance page walks through the appraisal process and what it means for patients in plain terms. The trial participants followed a reduced-calorie diet and increased their physical activity alongside the injections. Mounjaro did not work in isolation. Advice from UK prescribers consistently reflects that, the medicine reshapes appetite powerfully, but the lifestyle scaffolding around it determines how durable the results are. It is also worth knowing that SURMOUNT-1 ran to 72 weeks; many people reach their highest tolerated dose well before that, and the weight loss tends to continue, then plateau. If your progress feels slow in the first month or two, that is normal and expected at the lower doses.

For a broader overview of tirzepatide's evidence base, the tirzepatide information page on our site covers the full clinical picture in plain language.

Advice on side effects: what to expect and when to seek help

Nausea is the side effect most people ask about. It tends to peak in the first few days after a new dose, then ease, many patients find it barely noticeable after the second or third pen at a given strength. Eating smaller portions, avoiding very fatty meals and staying well hydrated genuinely helps. Some patients also notice unusual stomach sounds or gurgling, which is linked to slowed gastric emptying and is not typically a cause for concern. Constipation and loose stools can both occur, sometimes alternating; fibre and fluid intake matter here.

There are symptoms that do need prompt medical attention. Severe stomach pain that reaches through to your back (with or without vomiting) should not be waited out; it can indicate acute pancreatitis, a known but uncommon side effect that the MHRA highlighted in a Drug Safety Update in January 2026. Gallbladder problems, signs of a serious allergic reaction, and significant dehydration from persistent vomiting or diarrhoea all warrant a call to your GP or 111. The NHS tirzepatide medicine page carries a clear list of warning signs to watch for. You can also report any suspected side effect directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Practical advice for storage, routine and getting the most from each pen

Mounjaro pens are stored in the fridge, the door shelf works well, as long as the temperature stays between 2 and 8°C. Check the Patient Information Leaflet for the exact window of time the pen can be kept at room temperature if you need to travel; the leaflet is the definitive source, not general estimates online. Picking the same day each week for your injection and tying it to something fixed (a Sunday morning, the first day back at work) makes missing doses much less likely.

Injection sites rotate between your abdomen, thigh and upper arm. Rotating reduces the risk of skin reactions building up in one spot. If you are unsure about technique, that is exactly the kind of question our prescribers are there to answer, and our Mounjaro customer service contact page explains the different ways you can reach the team any day of the week. Advice on oral contraceptives is worth flagging here too: if you take the pill, UK guidance recommends adding a non-oral method of contraception for the first four weeks of Mounjaro treatment and for four weeks after each dose increase, because absorption of the pill may be affected. Transdermal HRT (patches or gels) is generally preferred over oral HRT for the same reason, discuss this with your doctor.

Advice on eligibility, NHS access and the private route

NICE recommends Mounjaro for adults with a BMI of 35 or above and at least one weight-related condition, thresholds that are 2.5 kg/m² lower for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds. NHS access is being phased in gradually; as of summer 2026, the NHS criteria are still quite narrow and waiting times through specialist services can be long. Many people who are clinically suitable for treatment seek it privately in the meantime.

If you are thinking about cost, a comparison of what different providers include in their pricing is worth reading before you decide, our Mounjaro price comparison guide sets out what to look for. Mounjaro is a prescription-only medicine, so any legitimate private route involves a clinical assessment, not just a checkout. At nume, at our pharmacy, every consultation is personally reviewed by a GPhC-registered Independent Prescriber the same day, and treatment is dispatched by DPD the next working day once approved. Our clinical lead's profile is public if you want to know more about who reviews your case. For questions the FAQs do not cover, you can find out exactly how to get in touch on our Mounjaro customer service page, which covers all the ways the team is reachable. When you are ready, check your eligibility through a free consultation.